Table 1.
First Author | Subjects Age Range | N = | Comparison | Preference | Comment |
Steine9 | GI Patients 45–79 y | 190 | BE v C | BE | Post hoc |
Durdey10 | GI Patients 19–88 y | 66 | BE v C | C | Post hoc |
VanNess11 | GI Patients 20–84 y | 189 | BE v C | C | Post hoc |
Elwood20 | Relatives of GI Patients 45–70 y | 232 | FS v C | FS = C | RCT; Subjects offered FS or C and differential compliance measured |
Dominitz12 | VAOP 50–75 y | 62 | FS v C | FS | Time trade off measure Least for FS. |
Frew13 | PCOP >25 y | 2294 | FOBT v FS | FOBT | Willingness to pay primary endpoint. Preference also collected. |
Leard14 | PCOP 50–75 y | 100 | FOBT, FS, BE, C | C preferred FOBT more likely to be done. | Post hoc 93% previously screened |
Dolan17 | PCOP >50 y | 96 | FOBT, FS, BE, C | FOBT | DARCT |
Pignone15 | PCOP 50–75 y | 227 | FOBT v FS | FOBT | DARCT |
Pignone18 | PCOP 50–75 y | 146 | FOBT v FS | FOBT | 4 levels of survey after varying quantities of information on colon cancer risk, conduct, test accuracy, cost. |
Wolf16 | PCOP >65 y | 57 | FOBT v FS | FOBT | DARCT |
Nelson | Non-patients 18–54 y | 80 | FOBT, FS, BE, C | FOBT |
GI Patients; Gastroenterology patients
BE; Barium enema.
C; Colonoscopy
FS; Fiberoptic sigmoidoscopy
FOBT; Fecal Occult Blot Testing
Post hoc; Preference measured after undergoing one or more of the above screening tests.
RCT; Randomised Controlled Trial
VAOP; Veteran's administration hospital outpatients
PCOP; Primary care outpatients
DARCT; Randomised trial to investigate the effectiveness of decision aids in increasing screening participation